Evaluation of the accuracy of serum MMP-9 as a test for colorectal cancer in a primary care population

BMC Cancer

Volumn 6, Issue , 2006, Pages

  Wilson, Sue ^a   Wakelam, Michael J O ^a   Hobbs, Richard F D ^a   Ryan, Angela V ^a   Dunn, Janet A ^c   Redman, Val D ^a   Patrick, Fiona ^b   Colbourne, Lynne ^a   Martin, Ashley ^a   Ismail, Tariq ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B;

ADULT; AGED; ANAL COMPLAINT; ARTICLE; BLOATING; BLOOD SAMPLING; CANCER DIAGNOSIS; CANCER INVASION; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; COLORECTAL DISEASE; COLORECTAL TUMOR; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; ENZYME ASSAY; ENZYME BLOOD LEVEL; FALSE POSITIVE RESULT; FEASIBILITY STUDY; GENERAL PRACTICE; HUMAN; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; NURSE RESEARCHER; PILOT STUDY; PRIMARY MEDICAL CARE; QUESTIONNAIRE; RISK BENEFIT ANALYSIS; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM;

AGED; COLORECTAL NEOPLASMS; EVALUATION STUDIES AS TOPIC; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; PRIMARY HEALTH CARE; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 33751431348     PISSN: 14712407     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-6-258     Document Type: Article

References (29)

1. National Cancer Intelligence Centre: Registrations of new cases of cancer diagnosed in England in by age group and sex. Rates per 100,000 population of new cases of cancer diagnosed in England in 2000, by age group and sex. [http://www.statistics.gov.uk/STATBASE/ ssdataset.asp?vlnk=6989]. Accessed 21 January 2004.
2. National Cancer Intelligence Centre: Deaths, 2001 registrations: Death by age, sex and underlying cause. [http://www.statistics.gov.uk/StatBase/ xsdataset.asp?vlnk=5670&Pos=l&ColRank=I&Rank=272]. Accessed 22 January 2004.
3. National Cancer Intelligence Centre: Five-year age-standardised relative survival (%) for adult patients diagnosed during 1991-95 and 1996-99, major cancers by sex, England and Wales. [http//www.statistics.gov.uk/ StatBase/ssdataset.asp?vlnk=709l&Pos=3&ColRank=l&Rank=144]. Accessed 2 February 2004.
4. National Cancer Institute: Colon and rectum cancer (invasive). Survival rates, by race, sex, diagnosis, year, stage and age. [http://seer.cancer.gov/cgi-bin/csr/search.pl]. Accessed 18 February 2004.
5. Chen C-D, Yen M-F, Wang W-M, Wong J-M, Chen TH-H: A casecohort study for the disease natural history of adenoma-carcinoma and de novo carcinoma and surveillance of colon and rectum after polypectomy: implication for efficacy of colonoscopy. British Journal of Cancer 2003, 88:1866-1873.
6. National Screening Committee: Criteria for appraising the viability, effectiveness and appropriateness of a screening programme. [http://www.nsc.nhs.uk/uknsc/uknscind.htm]. Accessed 18 February 2004.
7. Towler BP, Irwig L, Glasziou P, Weller D, Kewenter J: Screening for colorectal cancer using the faecal occult blood test, Hemocult (Cochrane Reviews). In The Cochrane Library Issue 4 Chicester, UK: John Wiley & Sons, Ltd; 2003.
8. Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM: Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1477.
9. UK Flexible Sigmoidoscopy Screening Trial Investigators: Single flexible sigmoidoscopy screening to prevent colorectal cancer: baseline findings of a UK multicentre randomised trial. Lancet 2002, 359:1291-1266.
10. Verne JECW, Aubrey R, Love SB, Talbot IC, Northover JMA. Population based randomised study of uptake and yield of screening by flexible sigmoidoscopy compared with screening with faecal occult blood testing. BMJ 1998, 317:182-185.
11. Waye JD, Kahn O, Auerbach ME: Complications of colonoscopy and flexible sigmoidoscopy. Gastrointestinal endoscopy clinics of North America 1996, 6:343-377.
12. Gatto NM, Frucht H, Sundararajan V, Jacobson JS, Grann VR, Neugut Al: Risk of Perforation After Colonoscopy and Sigmoidoscopy: A Population-Based Study. Journal of the National Cancer Institute 2003, 95:230-236.
13. UK colorectal cancer screening pilot group: Results of the first round of a demonstration pilot of screening for colorectal cancer in the United Kingdom. BMJ 2004, 329:133-7.
14. Collins HM, Morris TM, Watson SA: Spectrum of matrix metalloproteinase expression in primary and metastatic colon cancer: relationship to the tissue inhibitors of metalloproteinases and membrane type-I-matrix metalloproteinase. British Journal of Cancer 2001, 84(12):1664-1670.
15. Parsons SL, Watson SA, Collins HM, Griffin NR, Clarke PA, Steele RJC: Gelatinase (MMP-2 and -9) expression in gastrointestinal malignancy. British Journal of Cancer 1998, 78:1495-1502.
16. Heslin MJ, Yan J, Johnson MR, Weiss H, Diasio, RB, Urist MM: Role of Matrix Metalloproteinases in Colorectal Carcinogenesis. Annals of Surgery 2001, 233:786-792.
17. Garbett EA, Reed MWR. Brown NJ: Proteolysis in human breast and colorectal cancer. British Journal of Cancer 1999, 81:287-293.
18. Baker EA, Leaper DJ: The plasminogen activator and matrix metalloproteinase systems in colorectal cancer: relationship to tumour pathology. European Journal of Cancer 2003, 39:981-988.
19. Ransohoff DF, Feinstein AR: Problems of spectrum and bias in evaluating the efficacy of diagnostic tests. The New England Journal of Medicine 1978, 299:926-930.
20. Goehring C, Perrier A, Morabia A: Spectrum bias: a quantitative and graphical analysis of the variability of medical diagnostic test performance. Statistics in Medicine 2004, 23:125-135.
21. Department of Health: The NHS Cancer Plan. London 2000.
22. Atkin WS: Impending or pending? The national bowel cancer screening programme. BMJ 2006, 332:742.
23. Department of Health: Referral guidelines for suspected cancer. London 2000.
24. NICE: Referral guidelines for suspected cancer - quick reference guide. Clinical guideline 27 2005 [http//www.nice.org.uk]. National Institute for Health and Clinical Excellence
25. Underwood JCE, (Editor): General and Systematic Pathology Third edition. Churchill Livingstone; 2000.
26. O'Brien M, Winawer SJ, Zauber AG, Gottlieb LS, Sternberg SS, Diaz B, Dickersin GR, Ewing s, Geller s, Kasimian D, Komorowski R, Szpom A: The National Polyp Study Workgroup. The National Polyp Study. Patient and Polyp Characteristics Associated With High-Grade Dysplasia in Colorectal Adenomas. Gastroenterology 1990, 98:371-379.
27. Lieberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G, for Veterans Affairs Cooperative Study Group: Use of colonoscopy to screen asymptomatic adults for colorectal cancer. The New England Journal of Medicine 2000, 343:162-168.
28. Thiis-Evensen E, Hoff GS, Sauar J, Majak BM, Vatn MH: Flexible sigmoidoscopy or colonoscopy as a screening modality for colorectal adenomas in older age groups? Findings in a cohort of the normal population aged 63-72 years. Gut 1999, 45:834-839.
29. Office for National Statistics: Mid-2002 Population Estimates; quinary age groups and sex for local authorities in England and Wales; estimated resident population. [http://www.statistics.gov.uk/statbase/ Product.asp?vlnk=10687&image.x=18&image.y=9]. Accessed 18 February 2004.